Skip to main content
. 2016 Jun 7;55(12):1507–1520. doi: 10.1007/s40262-016-0418-z

Table 5.

Pharmacodynamic analysis of ceftobiprole treatment in patients treated in the intensive care unit [71]

Ceftobiprole 1000 mg (observed) Ceftobiprole 500 mg (extrapolated)
CLCR
50–79 mL/min
CLCR
80–150 mL/min
CLCR >150 mL/min CLCR
80–150 mL/min
CRCR >150 mL/min
T > MICa (h) 19.6 ± 4.1 14.5 ± 6.0 12.0 ± 5.0
fT > MICa (h) 18.2 ± 4.0 13.2 ± 5.5 10.8 ± 5.2 9.5 ± 4.3 7.3 ± 3.9
%fT > MICa (q8 h) >100 >100 >100 >100 91

Data are expressed as mean ± standard deviation, unless otherwise stated

CL CR creatinine clearance, MIC minimum inhibitory concentration, T > MIC time the plasma drug concentration is above the MIC, fT > MIC time the free (unbound) drug concentration is above the MIC, q8 h every 8 h

aMIC = 4 mg/L